[go: up one dir, main page]

AR039387A2 - Compuestos antibioticos de azalida - Google Patents

Compuestos antibioticos de azalida

Info

Publication number
AR039387A2
AR039387A2 ARP030101210A ARP030101210A AR039387A2 AR 039387 A2 AR039387 A2 AR 039387A2 AR P030101210 A ARP030101210 A AR P030101210A AR P030101210 A ARP030101210 A AR P030101210A AR 039387 A2 AR039387 A2 AR 039387A2
Authority
AR
Argentina
Prior art keywords
azalida
antibiotic compounds
compound
formula
antibiotic
Prior art date
Application number
ARP030101210A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22652702&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR039387(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AR039387A2 publication Critical patent/AR039387A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Un compuesto que es de fórmula (1) o una sal farmacéuticamente aceptable; en la cual R1 es OH o un compuesto de fórmula (2) y en la cual R2 es H ó CH3.
ARP030101210A 2000-01-27 2003-04-07 Compuestos antibioticos de azalida AR039387A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17848100P 2000-01-27 2000-01-27

Publications (1)

Publication Number Publication Date
AR039387A2 true AR039387A2 (es) 2005-02-16

Family

ID=22652702

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP010100319A AR030045A1 (es) 2000-01-27 2001-01-25 Composicion farmaceutica que contiene compuestos antibioticos de azalida , metodos para obtencion
ARP030101210A AR039387A2 (es) 2000-01-27 2003-04-07 Compuestos antibioticos de azalida

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP010100319A AR030045A1 (es) 2000-01-27 2001-01-25 Composicion farmaceutica que contiene compuestos antibioticos de azalida , metodos para obtencion

Country Status (21)

Country Link
US (2) US6514945B1 (es)
EP (1) EP1250343B1 (es)
JP (2) JP3893059B2 (es)
AR (2) AR030045A1 (es)
AT (1) ATE243703T1 (es)
AU (1) AU779748C (es)
BR (2) BRPI0017013B1 (es)
CA (1) CA2398485C (es)
CO (1) CO5251404A1 (es)
DE (1) DE60003586T2 (es)
DK (1) DK1250343T3 (es)
ES (1) ES2199884T3 (es)
MX (1) MXPA02007305A (es)
NZ (1) NZ518665A (es)
PA (1) PA8509801A1 (es)
PE (1) PE20011050A1 (es)
PT (1) PT1250343E (es)
TN (1) TNSN01017A1 (es)
TW (2) TWI331527B (es)
WO (1) WO2001055158A1 (es)
ZA (1) ZA200205958B (es)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003040782A (ja) * 2001-05-31 2003-02-13 Pfizer Prod Inc アザリド抗生物質組成物
AU2002317415A1 (en) * 2001-08-01 2003-02-17 Pfizer Products Inc. Azalide antibiotic compositions
PE20060693A1 (es) 2004-09-23 2006-09-01 Schering Plough Ltd Nuevos derivados de trifluorometansulfonanilida oxamida eter
ATE446677T1 (de) * 2004-11-19 2009-11-15 Schering Plough Ltd Kontrolle von parasiten bei tieren mittels verwendung von parasitiziden 2-phenyl-3-(1h- pyrrol-2-yl) acrylonitril-derivaten
AR054380A1 (es) * 2005-06-09 2007-06-20 Schering Plough Ltd Control de parasitos en animales con derivados de n- ((feniloxi) fenil) -1,1,1-trifluorometansulfonamida y de n-(fenilsulfanil) fenil) -1,1,1-trifluorometansulfonamida
US8119667B2 (en) * 2005-12-29 2012-02-21 Schering-Plough Animal Health Corporation Carbonates of fenicol antibiotics
US20070238700A1 (en) * 2006-04-10 2007-10-11 Winzenberg Kevin N N-phenyl-1,1,1-trifluoromethanesulfonamide hydrazone derivative compounds and their usage in controlling parasites
US20080044455A1 (en) * 2006-08-21 2008-02-21 Chaim Welczer Tonsillitus Treatment
CN101605756A (zh) * 2006-12-13 2009-12-16 先灵-普劳有限公司 氟苯尼考及其类似物的水溶性前药
WO2008076256A1 (en) * 2006-12-13 2008-06-26 Schering-Plough Ltd. Water-soluble prodrugs of chloramphenicol, thiamphenicol, and analogs thereof
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
SI2182945T1 (sl) 2007-06-27 2015-12-31 E.I. Du Pont De Nemours And Company Metoda za zatiranje škodljivcev pri živalih
US7795231B2 (en) * 2007-10-04 2010-09-14 Insite Vision Incorporated Concentrated aqueous azalide formulations
TWI401023B (zh) 2008-02-06 2013-07-11 Du Pont 中離子農藥
US8314252B2 (en) * 2008-07-30 2012-11-20 Intervet Inc. Process for preparing oxazoline-protected aminodiol compounds useful as intermediates to florfenicol
UA110924C2 (uk) 2009-08-05 2016-03-10 Е. І. Дю Пон Де Немур Енд Компані Мезоіонні пестициди
WO2011017347A2 (en) 2009-08-05 2011-02-10 E. I. Du Pont De Nemours And Company Mesoionic pesticides
UA107804C2 (en) 2009-08-05 2015-02-25 Du Pont Mixtures of pesticides mezoionnyh
US20120122679A1 (en) 2009-08-05 2012-05-17 E. I. Du Pont De Nemours And Company Mesoionic pesticides
MX2012013758A (es) 2010-05-27 2013-01-24 Du Pont Forma cristalina de 4-[5-[3-cloro-5-trifluorometil)fenil]-4,5-dihi dro-5-(trifluorometil)-3-isoxazolil]-n-[2-oxo-2-[(2,2,2-trifluoro etil)amino]etil]-1-naftalenocarboxamida.
EP4324524A2 (en) 2010-07-01 2024-02-21 Elanco Tiergesundheit AG Antibiotic compositions
WO2012012782A1 (en) * 2010-07-23 2012-01-26 Acea Biotech, Inc. Antifungal and antiparasitic polyene macrolides
WO2012087630A1 (en) 2010-12-20 2012-06-28 E.I. Du Pont De Nemours And Company Pyridine and pyrimidine compounds for controlling invertebrate
US20140113934A1 (en) 2011-06-20 2014-04-24 E I Du Pont De Nemours And Company Heterocyclic compounds for treating helminth infections
WO2013013834A1 (en) 2011-07-27 2013-01-31 Farma Grs, D.O.O. New crystalline forms of tulathromycin
EP2776866B1 (en) 2011-11-11 2020-06-17 Exxonmobil Upstream Research Company Method for determining the location, size, and fluid composition of a subsurface hydrocarbon accumulation
RU2613219C2 (ru) 2011-11-11 2017-03-15 Эксонмобил Апстрим Рисерч Компани Способ наблюдения за коллектором с использованием данных о скученных изотопах и/или инертных газах
WO2013081783A1 (en) 2011-11-28 2013-06-06 E. I. Du Pont De Nemours And Company N- (4 -quinolinylmethyl) sulfonamide derivatives and their use as anthelmintics
WO2013158422A1 (en) 2012-04-17 2013-10-24 E. I. Du Pont De Nemours And Company Heterocyclic compounds for controlling invertebrate pests
WO2014099837A1 (en) 2012-12-18 2014-06-26 E. I. Du Pont De Nemours And Company Sulfonamide anthelmintics
US9044508B2 (en) * 2013-03-15 2015-06-02 Insite Vision Corporation Concentrated aqueous azalide formulations
CA3130061C (en) 2013-04-04 2024-05-28 President And Fellows Of Harvard College Macrolides and methods of their preparation and use
CN103588833B (zh) * 2013-10-30 2016-08-17 北京科技大学 动物抗菌素泰拉霉素的制备方法
AU2014385229B2 (en) 2014-03-07 2017-04-20 Exxonmobil Upstream Research Company Exploration method and system for detection of hydrocarbons from the water column
CN104119413B (zh) * 2014-07-29 2016-08-24 华中农业大学 一种土拉霉素残留标示物的合成方法
WO2016057798A1 (en) 2014-10-08 2016-04-14 President And Fellows Of Harvard College 14-membered ketolides and methods of their preparation and use
EP3273969A4 (en) 2015-03-25 2018-11-21 President and Fellows of Harvard College Macrolides with modified desosamine sugars and uses thereof
CN108473524B (zh) * 2016-01-18 2021-11-02 浙江海正药业股份有限公司 一种泰拉霉素的制备方法及其中间体
WO2020106636A1 (en) * 2018-11-19 2020-05-28 Zikani Therapeutics, Inc. C11-cyclic substituted 13-membered macrolides and uses thereof
PT4118091T (pt) * 2020-03-12 2025-08-20 Zoetis Services Llc Ureia azalídeos imunomoduladores
KR102589130B1 (ko) * 2021-03-24 2023-10-13 삼진제약주식회사 N-옥소 피리딘 화합물 발생을 억제하는 안질환 예방 또는 치료용 점안 조성물
JP7770547B2 (ja) 2021-09-07 2025-11-14 ゾエティス・サービシーズ・エルエルシー 免疫調節性アザライド
EP4289268A1 (en) * 2022-06-07 2023-12-13 The Procter & Gamble Company Antimicrobial composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000074A (es) * 1997-06-11 1999-01-08 Pfizer Prod Inc Derivados de macrolidos c-4 sustituidos
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
US6128174A (en) 1997-08-29 2000-10-03 Stereotaxis, Inc. Method and apparatus for rapidly changing a magnetic field produced by electromagnets
JP2001515865A (ja) * 1997-09-10 2001-09-25 メルク エンド カムパニー インコーポレーテッド 家畜抗菌剤としての９ａ−アザライド
ATE392427T1 (de) * 1999-05-18 2008-05-15 Pfizer Prod Inc Neue kristalline formen eines macrolidantibiotikums

Also Published As

Publication number Publication date
AU779748C (en) 2005-12-08
BR0017013A2 (pt) 2010-07-13
MXPA02007305A (es) 2002-11-29
ZA200205958B (en) 2003-09-29
TWI331527B (en) 2010-10-11
US20030013860A1 (en) 2003-01-16
BR0017013A (pt) 2002-10-22
JP2006282676A (ja) 2006-10-19
DE60003586D1 (de) 2003-07-31
ATE243703T1 (de) 2003-07-15
BRPI0017013B8 (pt) 2022-11-16
PA8509801A1 (es) 2002-02-21
DE60003586T2 (de) 2004-01-08
JP2004500384A (ja) 2004-01-08
CA2398485A1 (en) 2001-08-02
US6667393B2 (en) 2003-12-23
CA2398485C (en) 2008-01-29
AU779748B2 (en) 2005-02-10
NZ518665A (en) 2005-02-25
ES2199884T3 (es) 2004-03-01
AU1722801A (en) 2001-08-07
JP3893059B2 (ja) 2007-03-14
WO2001055158A1 (en) 2001-08-02
PE20011050A1 (es) 2001-10-19
BRPI0017013B1 (pt) 2015-07-14
TWI318880B (en) 2010-01-01
EP1250343A1 (en) 2002-10-23
PT1250343E (pt) 2003-11-28
US6514945B1 (en) 2003-02-04
AR030045A1 (es) 2003-08-13
TW201006476A (en) 2010-02-16
DK1250343T3 (da) 2003-09-22
US20030073825A1 (en) 2003-04-17
TNSN01017A1 (fr) 2005-11-10
EP1250343B1 (en) 2003-06-25
CO5251404A1 (es) 2003-02-28

Similar Documents

Publication Publication Date Title
AR039387A2 (es) Compuestos antibioticos de azalida
CR6529A (es) Acidos 3-propil-gama-aminobutiricos mono y disustituidos
LU91624I2 (fr) Canakinumab et ses dérivés pharmaceutiquement acceptables (ILARIS®)
CY1107634T1 (el) Φαρμακευτικη συνθεση
CO5600999A2 (es) Composiciones farmaceuticas que comprenden inhibidores de valsartan y endopeptidasa neutra
LU92381I2 (fr) Macitentan et ses dérivés pharmaceutiquement acceptables (OPSUMIT)
UY27638A1 (es) Compuesto inhibidor de la hepatitis c
DE60336850D1 (en) Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren
DK1333799T3 (da) Oral sammensætning til forbedret fjernelse af misfarvning fra tænder
PL361404A1 (en) Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
ATE306261T1 (de) Antithrombosemittel
IL133623A0 (en) Antithrombotic agents
LU92024I2 (fr) Pasireotide et ses dérivés pharmaceutiquement acceptables (SIGNIFOR)
ES2546291T3 (es) 17-Alfa-sustituida, 11-beta-sustituida-4-arilo y 21-sustituida 19-norpregnadienodionas como agentes antiprogestacionales
PT1109812E (pt) Pirrolobenzodiazepinas
LU92513I2 (fr) Sofosbuvir et ses dérivés pharmaceutiquement acceptables (solvaldi)
TR200100432T2 (tr) Hepatit C inhibitörü tri-peptidler
AR015379A1 (es) Ascorbil-fosforil-colesterol
PL352638A1 (en) Novel derivatives and analogues of galanthamin
NO973539D0 (no) Prolinderivater anvendelige som inhibitorer for human leukocyttelastase
CO4990974A1 (es) Un derivado carbohidrato
ATE308540T1 (de) Antithrombosemittel
AR026243A1 (es) Solucion oral de galantamina
ATE315026T1 (de) Amlodipin-hemimaleat
ZA949562B (en) Conjugates of hirudin and lipophilic compounds

Legal Events

Date Code Title Description
FG Grant, registration